Earnings Updates

CVS delivered its best full-year cash flow in recent memory. The question now is whether the margin trajectory can hold through 2027.

GE Vernova booked $18.3B in Q1 orders and generated more free cash flow in one quarter than all of 2025.

Texas Instruments grew industrial revenue 30% year-over-year and data center 90%. The real question is whether it holds past Q2.

IBM stock posted its strongest Q1 free cash flow in a decade. Here's what the numbers say about where it's headed next.

Zions Bancorp stock slips after Q1 earnings beat of $1.56 vs. $1.43 est., as a small revenue miss and cautious outlook weigh on investor sentiment.

ServiceNow stock drops 12% after Q1 earnings narrowly beat estimates, as Middle East conflict weighs on subscription revenue and investor sentiment.

Lam Research posted record revenue and beat EPS guidance, but the real question is whether a 50% gross margin can hold.

D.R. Horton stock rallies after beating Q2 EPS estimates by $0.10, with home orders jumping 11% year-over-year to nearly 25,000 homes.

D.R. Horton stock rallies after beating Q2 EPS estimates by $0.10, with home orders jumping 11% year-over-year to nearly 25,000 homes.

CrowdStrike posted an all-time record quarter and returned to GAAP profitability. The debate now is whether 47% net new ARR growth is repeatable.

Energy Transfer posted a partnership record in 2025, but the real question is whether $5 billion in annual CapEx converts into EBITDA growth on schedule.

Vertiv's Q4 orders surged 252% year-over-year, pushing backlog to $15 billion. That changes how you model 2027.

Lam Research posted record revenue and EPS above guidance, but the TIKR model puts fair value only 8% above today's price.

Danaher stock rises after Q1 earnings beat, raised EPS guidance, and strong bioprocessing order trends signal an early multi-year recovery cycle.

Quest Diagnostics stock climbs after Q1 earnings and revenue beat, with raised full-year guidance driven by strong diagnostic and consumer demand.

Alaska Air Group stock falls as the airline pulls full-year guidance, citing surging jet fuel costs from the Iran conflict despite strong demand.

WESCO delivered record Q4 revenue and record backlog, but gross margin has barely moved in eight quarters. That tension defines the 2026 setup.

TransDigm beat Q1 expectations, raised full-year guidance, and still fell 5%. The TIKR model says the stock is 57% undervalued.

McDonald's posted 6.8% U.S. comp growth and record single-day sales in Q4. The question is whether 2026 can sustain the momentum.

3M beat Q1 profit estimates but revenue growth disappointed, sending 3M stock down 1.8% as investors weighed mixed results against reaffirmed full-year guidance.

UnitedHealth stock surges 9% after Q1 earnings beat and raised 2026 guidance, as the insurer improves medical cost management and operations.

RTX stock dips despite a strong Q1 beat and raised guidance, as tariff concerns and easing Iran tensions weigh on investor sentiment.

Tractor Supply stock drops 9% after Q1 earnings and revenue miss, driven by pet category weakness, though full-year guidance was reaffirmed.

Cognex posted its first organic growth year since 2021 and hit a margin milestone a full year ahead of schedule. The setup for 2026 is real.

Clover hit $3.3 billion in 2025 revenue, up 23%. The real question is whether the margin trough is temporary or structural.

Veeva crossed $3 billion in revenue and posted Q4 results ahead of guidance. The question now is whether R&D Cloud can keep the growth rate intact.

Estée Lauder posted 43% EPS growth and raised its full-year outlook. But the revenue recovery is still running behind the margin story.

American Express closed 2025 with record revenue and a Platinum Card retention rate of 99%. The question now is whether margins can hold.